Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Non-Current Assets (2019 - 2025)

Pulmonx (LUNG) has disclosed Non-Current Assets for 6 consecutive years, with -$120.0 million as the latest value for Q2 2025.

  • Quarterly Non-Current Assets fell 553.45% to -$120.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$50.3 million through Jun 2025, up 54.61% year-over-year, with the annual reading at $26.6 million for FY2024, 2.77% down from the prior year.
  • Non-Current Assets for Q2 2025 was -$120.0 million at Pulmonx, down from $26.6 million in the prior quarter.
  • The five-year high for Non-Current Assets was $27.4 million in Q4 2023, with the low at -$227.6 million in Q3 2021.
  • Average Non-Current Assets over 5 years is -$36.0 million, with a median of $22.3 million recorded in 2022.
  • The sharpest move saw Non-Current Assets skyrocketed 109.18% in 2024, then crashed 553.45% in 2025.
  • Over 5 years, Non-Current Assets stood at $27.2 million in 2021, then fell by 9.01% to $24.7 million in 2022, then increased by 10.66% to $27.4 million in 2023, then dropped by 2.77% to $26.6 million in 2024, then crashed by 551.17% to -$120.0 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at -$120.0 million, $26.6 million, and $26.5 million for Q2 2025, Q4 2024, and Q2 2024 respectively.